SCM
BDSX icon

Sio Capital Management’s Biodesix BDSX Stock Holding History

Sio Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-216,926
Closed -$7.72M – 52
2024
Q3 		$7.72M Sell
216,926
-467
-0.2% -$16.1K 3.06% 13
2024
Q2 		$6.65M Buy
+217,393
New +$6.21M 1.8% 17

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return

Sio Capital Management's BDSX Position: Q4 2024 in Review

Sio Capital Management sold out of Biodesix (BDSX) in Q4 2024, closing a stake of 216,926 shares — an estimated $7.72M sold.

Sio Capital Management first reported a position in BDSX in Q2 2024 and held it in 2 quarters. The position peaked at $7.72M in Q3 2024. 58 funds tracked by Wall St. Rank hold BDSX as of Q4 2024.

  • Sio Capital Management reported no remaining Biodesix position as of Q4 2024 after selling out during the quarter.
  • Sio Capital Management sold 216,926 Biodesix shares in Q4 2024, an estimated $7.72M.
  • Sio Capital Management first reported a position in Biodesix in Q2 2024 and held it in 2 quarters.
  • Sio Capital Management's Biodesix position peaked at $7.72M in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Biodesix as of Q4 2024.

Based on Sio Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.